Limited official informationFDA Drug Enforcement ReportsRecall date: Apr 29, 2026

Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01

1Is my item affected?

Compare the complete identifiers. Name similarity alone is not a confirmed match.

Affected variants from the official event record
Product or model	Codes and lots	Quantity	Recall number
Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01	Lots# H03125, H03225, H03325, Exp Date: 2027/08	9384 bottles	D-0486-2026

The agency's statement is shown without a site-authored severity score.

CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.

Agency classification: Class II

Only instructions associated with this recall event qualify as an action.

Consumer action is not available in the associated official record. The site does not infer or generate a replacement.

The linked agency record controls if any information differs.

Official scope

US Nationwide.

Distribution is context, not a confirmed item match. Compare the model, lot, UPC, NDC, or serial number above.

No material affected-item, risk, action, or status change has been recorded since this page entered the tracker.